In-vitro toxicology testing Market Overview
In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of the new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.
Increasing technological advancements, rising research & development in cell culture, growing demand for in-vitro toxicology tests over the conventional in-vivo tests, increasing awareness towards toxicity testing studies, rising health-consciousness amongst individuals, growing economic status in emerging nations, existence of favorable regulatory authorities for toxicology testing using the in-vitro tests are driving the growth of in-vitro toxicology testing market. However, scarcity of in-vitro models to detect immunostimulation & autoimmunity, lack of predictive ability of in vitro testing over in vivo testing, technological advancements limiting the use & decreasing adoption rate are the major factors that restrain the growth of in-vitro toxicology testing market.
In-vitro toxicology testing Market Forecast Report (2018-2023)
Global In-vitro toxicology testing Market value is expected to reach USD 35712 Million by 2023 from USD 18418 Million in 2018, growing at a CAGR of 14.16% for the next five years 2018-2023
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/global-in-vitro-toxicology-testing-market-184/
In-vitro toxicology testing Market Segmentation
Global in-vitro toxicology testing market is segmented based on the product, type, toxicity endpoints & tests, technology, method, and industry. Based on product, the market is further sub-segmented as assays, reagent & lab ware, and service. Based on the type, the market is segmented as ADME, dose, and toxic substance. Toxicity endpoints & tests are further segmented as systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. Technology is further segmented into OMICS technologies & cell culture technology. In-vitro toxicology testing market segmentation, By the method, the market is segmented as in-silico method, biochemical assays, cellular assays, and ex vivo models. The market, by industry, is sub-segmented as cosmetics & household products, pharmaceutical, diagnostics, chemical, & food.
On the basis of geographical region, the global in-vitro toxicology testing market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Europe is estimated to account for the largest share of 32.5% of the global in-vitro toxicology testing market in 2018, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.10% during the forecast period 2018-2023
The major companies dominating this market for its products and services are
- Covance, Inc. (A subsidiary of LabCorp) (U.S.),
- Agilent Technologies, Inc. (U.S.),
- Bio-Rad Laboratories, Inc. (U.S.),
- Euro fins Scientific SE (Luxembourg),
- General Electric Company (U.S.),
- BioReliance, Inc. (U.S.),
- Charles River Laboratories International, Inc. (U.S.),
- Thermo Fisher Scientific, Inc. (U.S.),
- Catalent (U.S.),
- Cyprotex (U.K.).
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Sales Manager at Market Data Forecast